DE19951617A1 - Zubereitungen pharmazeutische Wirkstoffe - Google Patents

Zubereitungen pharmazeutische Wirkstoffe

Info

Publication number
DE19951617A1
DE19951617A1 DE19951617A DE19951617A DE19951617A1 DE 19951617 A1 DE19951617 A1 DE 19951617A1 DE 19951617 A DE19951617 A DE 19951617A DE 19951617 A DE19951617 A DE 19951617A DE 19951617 A1 DE19951617 A1 DE 19951617A1
Authority
DE
Germany
Prior art keywords
active ingredient
component
dosage form
solid dosage
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19951617A
Other languages
German (de)
English (en)
Inventor
Robert Heger
Joerg Breitenbach
Gunther Berndl
Rudolf Binder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to DE19951617A priority Critical patent/DE19951617A1/de
Priority to PL00354991A priority patent/PL354991A1/xx
Priority to PCT/EP2000/010205 priority patent/WO2001030372A2/fr
Priority to CA002388614A priority patent/CA2388614A1/fr
Priority to JP2001532789A priority patent/JP2004500343A/ja
Priority to EP00972786A priority patent/EP1223960A2/fr
Priority to CN00814940A priority patent/CN1384753A/zh
Publication of DE19951617A1 publication Critical patent/DE19951617A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19951617A 1999-10-26 1999-10-26 Zubereitungen pharmazeutische Wirkstoffe Withdrawn DE19951617A1 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE19951617A DE19951617A1 (de) 1999-10-26 1999-10-26 Zubereitungen pharmazeutische Wirkstoffe
PL00354991A PL354991A1 (en) 1999-10-26 2000-10-17 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
PCT/EP2000/010205 WO2001030372A2 (fr) 1999-10-26 2000-10-17 Preparations de principes actifs pharmaceutiques
CA002388614A CA2388614A1 (fr) 1999-10-26 2000-10-17 Preparations de principes actifs pharmaceutiques
JP2001532789A JP2004500343A (ja) 1999-10-26 2000-10-17 医薬製剤
EP00972786A EP1223960A2 (fr) 1999-10-26 2000-10-17 Preparations de principes actifs pharmaceutiques
CN00814940A CN1384753A (zh) 1999-10-26 2000-10-17 活性药物成分的制备物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19951617A DE19951617A1 (de) 1999-10-26 1999-10-26 Zubereitungen pharmazeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
DE19951617A1 true DE19951617A1 (de) 2001-05-03

Family

ID=7926968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19951617A Withdrawn DE19951617A1 (de) 1999-10-26 1999-10-26 Zubereitungen pharmazeutische Wirkstoffe

Country Status (7)

Country Link
EP (1) EP1223960A2 (fr)
JP (1) JP2004500343A (fr)
CN (1) CN1384753A (fr)
CA (1) CA2388614A1 (fr)
DE (1) DE19951617A1 (fr)
PL (1) PL354991A1 (fr)
WO (1) WO2001030372A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089773A2 (fr) * 2001-05-09 2002-11-14 Novartis Ag Compositions pharmaceutiques solides contenant de la cyclosporine
WO2006131481A1 (fr) * 2005-06-09 2006-12-14 Basf Aktiengesellschaft Production de solutions solides a base de substances actives peu solubles, par surchauffe de courte duree et sechage rapide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0816053B2 (ja) * 1986-12-04 1996-02-21 大正製薬株式会社 貼付剤の製造方法
JPH0436237A (ja) * 1990-06-01 1992-02-06 Taiho Yakuhin Kogyo Kk 抗腫瘍性複合製剤
WO1993010767A1 (fr) * 1991-12-05 1993-06-10 Alfatec-Pharma Gmbh Forme d'administration perorale de medicaments peptidiques, notamment l'insuline
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
JP4189044B2 (ja) * 1997-07-01 2008-12-03 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089773A2 (fr) * 2001-05-09 2002-11-14 Novartis Ag Compositions pharmaceutiques solides contenant de la cyclosporine
WO2002089773A3 (fr) * 2001-05-09 2003-02-06 Novartis Ag Compositions pharmaceutiques solides contenant de la cyclosporine
WO2006131481A1 (fr) * 2005-06-09 2006-12-14 Basf Aktiengesellschaft Production de solutions solides a base de substances actives peu solubles, par surchauffe de courte duree et sechage rapide

Also Published As

Publication number Publication date
CN1384753A (zh) 2002-12-11
EP1223960A2 (fr) 2002-07-24
PL354991A1 (en) 2004-03-22
WO2001030372A2 (fr) 2001-05-03
JP2004500343A (ja) 2004-01-08
CA2388614A1 (fr) 2001-05-03
WO2001030372A3 (fr) 2001-11-01

Similar Documents

Publication Publication Date Title
EP1162953B1 (fr) Formes d'administration pharmaceutiques mecaniquement stables, qui contiennent des substances tensioactives liquides ou semi-solides
DE60023465T2 (de) Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
DE69222182T2 (de) Verfahren für die herstellung einer festen dispersion
DE69629755T3 (de) Irbesartanhaltiges Arzneimittel
DE10046541A1 (de) Mechanisch stabile darreichungsformen, enthaltend Ubichinone
DE3013839A1 (de) Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE19819273A1 (de) Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
EP0596203A1 (fr) Préparations sous forme de particules solides contenant des principes actifs et des polymères hydrosolubles
EP1284717A1 (fr) Formulation a base d'heparine, de glycosaminoglycane ou d'heparinoide et utilisation de ladite formulation et base de la formulation
WO2001000175A1 (fr) Formes d'administration pharmaceutiques mecaniquement stables, contenant des agents tensioactifs liquides ou semi-solides
EP0615442B1 (fr) Matrice thermocollo dale reglee par des sols a base de gelatine utile dans des formes d'administration perorale a action prolongee
EP2595607A2 (fr) Médicament d'administration orale contenant un mélange de silodosine et d'un copolymère basique
EP0697867B1 (fr) Compositions sous forme de solutions solides
WO2009056266A2 (fr) Candesartan cilexetil
DE69910188T2 (de) Arzneiformen enthaltend carvedilol
EP1169023B1 (fr) Procèdè de la preparation des AUXILIAIRES DE SOLUBILISATION PULVERULENTS POUR FORMES D'ADMINISTRATION PHARMACEUTIQUES SOLIDES
EP1142571B1 (fr) Procédé pour la production de formes galéniques solides à base de créatine et formes galéniques ainsi obtenues
DE19951617A1 (de) Zubereitungen pharmazeutische Wirkstoffe
CA2208571A1 (fr) Particule de resine, substance medicale et preparation pharmaceutique contenant cette particule de resine
EP1753401A1 (fr) Granulat rapidement soluble de bromhexine / hydrochlorure de bromhexine, procede de fabrication dudit granulat et son utilisation
DE19821951A1 (de) Cyclosporin-Zubereitungen
DE19809242A1 (de) Verfahren zur Herstellung von festen, sphärischen Formkörpern, enthaltend pharmazeutische Wirkstoffe in einer Bindemittelmatrix
DE19930454A1 (de) Feste Paroxetin enthaltende Zubereitungen
DE102019119163A1 (de) Nanostrukturierte Ibuprofen-Zusammensetzungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP1682086A2 (fr) Formulation de medicament contenant un antagoniste de ltb sb 4 /sb , et procedes de production et utilisation de cette formulation de medicament

Legal Events

Date Code Title Description
8130 Withdrawal